Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
12.46
+0.39 (3.23%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Olema Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 18.31 | 18.82 | 24.71 | 20.39 | 7.82 | 0.4 | |
| Research & Development | 104.32 | 86.14 | 82.27 | 51.1 | 13.7 | 3.92 | |
| Operating Expenses | 122.63 | 104.96 | 106.99 | 71.49 | 21.53 | 4.32 | |
| Operating Income | -122.63 | -104.96 | -106.99 | -71.49 | -21.53 | -4.32 | |
| Interest Expense | - | - | - | - | -0.65 | - | |
| Interest & Investment Income | 11.93 | 8.33 | 2.23 | 0.44 | 0.06 | 0.01 | |
| Other Non Operating Income (Expenses) | 0.07 | -0.02 | -0.03 | -0.05 | - | - | |
| Pretax Income | -109.63 | -96.66 | -104.79 | -71.1 | -22.12 | -4.32 | |
| Net Income | -109.63 | -96.66 | -104.79 | -71.1 | -22.12 | -4.32 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.87 | - | |
| Net Income to Common | -109.63 | -96.66 | -104.79 | -71.1 | -23.99 | -4.32 | |
| Shares Outstanding (Basic) | 53 | 45 | 40 | 40 | 7 | 3 | |
| Shares Outstanding (Diluted) | 53 | 45 | 40 | 40 | 7 | 3 | |
| Shares Change (YoY) | 31.48% | 13.13% | 1.19% | 462.91% | 170.75% | 2.80% | |
| EPS (Basic) | -2.07 | -2.14 | -2.62 | -1.80 | -3.42 | -1.66 | |
| EPS (Diluted) | -2.07 | -2.14 | -2.62 | -1.80 | -3.42 | -1.66 | |
| Free Cash Flow | -92.43 | -83.73 | -82.43 | -52.27 | -19.92 | -3.08 | |
| Free Cash Flow Per Share | -1.74 | -1.85 | -2.06 | -1.32 | -2.84 | -1.19 | |
| EBITDA | -122.27 | -104.58 | -106.63 | -71.33 | -21.52 | -4.31 | |
| D&A For EBITDA | 0.36 | 0.38 | 0.36 | 0.16 | 0.01 | 0.01 | |
| EBIT | -122.63 | -104.96 | -106.99 | -71.49 | -21.53 | -4.32 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.